BioPhausia is a Swedish specialty pharma company. BioPhausia focuses on marketing and sales of own products, licensed products and parallel-imported products. The portfolio includes strong brands such as Novalucol, Citodon and Mollipect. BioPhausia AB (publ) has its registered office in Stockholm and is listed on the Nasdaq OMX Nordic Exchange, Small cap.
View Top Employees from BioPhausia ABWebsite | http://www.biophausia.se |
Revenue | $4.4 million |
Employees | 1 (1 on RocketReach) |
Founded | 1994 |
Address | Blasieholmsgatan 2, Stockholm, Stockholm 111 48, SE |
Phone | (468) 407-6430 |
Technologies |
JavaScript,
HTML,
PHP
+5 more
(view full list)
|
Industry | Pharmaceuticals, Drug Manufacturing & Research, Biotechnology, Science and Engineering, Healthcare, Medical, Health Care, Pharmaceutical |
SIC | SIC Code 28 Companies, SIC Code 2834 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular BioPhausia AB employee's phone or email?
The BioPhausia AB annual revenue was $4.4 million in 2023.
1 people are employed at BioPhausia AB.
BioPhausia AB is based in Stockholm, Stockholm.
The NAICS codes for BioPhausia AB are [325, 32541, 3254, 32].
The SIC codes for BioPhausia AB are [28, 2834, 283].